These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16781787)

  • 1. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.
    Christodoulou C; Schally AV; Chatzistamou I; Kondi-Pafiti A; Lamnissou K; Kouloheri S; Kalofoutis A; Kiaris H
    Regul Pept; 2006 Sep; 136(1-3):105-8. PubMed ID: 16781787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
    Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
    Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
    Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
    Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor.
    Barabutis N; Tsellou E; Schally AV; Kouloheri S; Kalofoutis A; Kiaris H
    Proc Natl Acad Sci U S A; 2007 Mar; 104(13):5575-9. PubMed ID: 17372203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.
    Kiaris H; Chatzistamou I; Schally AV; Halmos G; Varga JL; Koutselini H; Kalofoutis A
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9512-7. PubMed ID: 12867592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
    Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL
    J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
    Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
    Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
    Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
    Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extrapituitary effects of the growth hormone-releasing hormone.
    Kiaris H; Schally AV; Kalofoutis A
    Vitam Horm; 2005; 70():1-24. PubMed ID: 15727800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.
    Chatzistamou I; Schally AV; Kiaris H; Politi E; Varga J; Kanellis G; Kalofoutis A; Pafiti A; Koutselini H
    Eur J Endocrinol; 2004 Sep; 151(3):391-6. PubMed ID: 15362970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
    Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
    Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.
    Kiaris H; Schally AV; Busto R; Halmos G; Artavanis-Tsakonas S; Varga JL
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):196-200. PubMed ID: 11773624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the pituitary somatotroph cell by GHRH and its receptor.
    Mayo KE; Miller T; DeAlmeida V; Godfrey P; Zheng J; Cunha SR
    Recent Prog Horm Res; 2000; 55():237-66; discussion 266-7. PubMed ID: 11036940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in gene expression of the growth hormone secretagogue and growth hormone-releasing hormone receptors in Holstein-Friesian cattle.
    Komatsu M; Kojima M; Okamura H; Nishio M; Kaneda M; Kojima T; Takeda H; Malau-Aduli AE; Takahashi H
    Domest Anim Endocrinol; 2012 Feb; 42(2):83-93. PubMed ID: 22056236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.
    Havt A; Schally AV; Halmos G; Varga JL; Toller GL; Horvath JE; Szepeshazi K; Köster F; Kovitz K; Groot K; Zarandi M; Kanashiro CA
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17424-9. PubMed ID: 16299104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
    Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
    Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
    Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.